JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2000) 166, 437-445       DOI: 10.1677/joe.0.1660437
© 2000 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arcelloni, C
Right arrow Articles by Paroni, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arcelloni, C
Right arrow Articles by Paroni, R
Journal of Endocrinology, Vol 166, Issue 2, 437-445
Copyright © 2000 by Society for Endocrinology


Articles

Processing and release of human proinsulin-cleavage products into culture media by different engineered non-endocrine cells: a specific assessment by capillary electrophoresis

C Arcelloni, L Falqui, S Martinenghi, A Stabilini, AE Pontiroli, and R Paroni


The aim of this study was to compare the metabolic pathway to mature insulin through the intermediate forms (32-33 split, 65-66 split, des31,32 and des64,65) in human or murine cells engineered for the release of wild-type human proinsulin and in a genetically mutated one, in the search for a new approach for an insulin-dependent diabetes mellitus cure by gene therapy. Primary human fibroblasts, myoblasts and stabilized cell lines (HepG2 and NIH3T3) were transduced either with a retroviral vector coding for wild-type proinsulin or for a genetically mutated one, carrying cleavage sites sensitive to furin. The pattern of all the proinsulin cleavage products released into the cell culture supernatants was analyzed by capillary electrophoresis. All the cells transduced with the wild-type gene released intact proinsulin. HepG2 released a considerable amount of 65-66 split and des64,65, while primary myoblasts released all the intermediate forms and a limited amount of mature insulin. All the cells transduced with a furin-sensitive proinsulin gene released a higher amount of mature insulin (23-59% conversion yield) than the cells expressing wild-type proinsulin, whereas the total insulin was nearly constant. Only primary cells released all the cleavage products. Screening a wide variety of non-endocrine cells has revealed a large difference in the processing and release of immature and mature insulin forms, pointing to human hepatic cells as the most efficacious. Capillary electrophoresis provided on-line and in a single run a complete overview of the proinsulin metabolic pathway in different cells.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
L. Marzban, G. Trigo-Gonzalez, and C. B. Verchere
Processing of Pro-Islet Amyloid Polypeptide in the Constitutive and Regulated Secretory Pathways of {beta} Cells
Mol. Endocrinol., August 1, 2005; 19(8): 2154 - 2163.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. L. Zhu, A. Abdo, J. F. Gesmonde, K. C. Zawalich, W. Zawalich, and P. S. Dannies
Aggregation and Lack of Secretion of Most Newly Synthesized Proinsulin in Non-{beta}-Cell Lines
Endocrinology, August 1, 2004; 145(8): 3840 - 3849.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Endocrinology.